IRON
Disc Medicine Inc.
64.50$
+1.4%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -351.5% | – | – | – | |
| – | – | – | – | – | -4.6% | -6.5% | -20.7% | – | – | – | – | -63.7% | -31.2% | -66.7% | +0.0% | +4.0% | +323.1% | -90.0% | -18.2% | +122.2% | +325.0% | +2.4% | +2.3% | +0.0% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -32.7% | +21.7% | – | – | -8.0% | +24.1% | -6.1% | -38.1% | -1.4% | +2.2% | +161.4% | -2.1% | -40.0% | +19.2% | +56.5% | +5.0% | -0.9% | +5.1% | +0.5% | +12.0% | +66.8% | +8.7% | -8.2% | -0.7% | +2.2% | – | |
| – | -19.5% | +7.4% | -58.7% | +830.9% | +16.5% | -8.8% | +2.3% | -58.1% | +101.1% | -39.7% | -72.5% | +594.5% | +5.7% | -13.2% | +57.5% | +8.5% | -5.0% | +10.9% | +19.4% | +24.9% | +23.9% | +15.0% | +19.5% | +13.9% | -23.2% | – | |
| – | -30.8% | +19.2% | -189.7% | – | -1.0% | +13.1% | -3.8% | -43.9% | +20.6% | -12.8% | +103.5% | +17.8% | -31.0% | +9.4% | +56.7% | +5.9% | -1.9% | +6.5% | +5.2% | +15.6% | +53.7% | +10.2% | -1.1% | +3.8% | -6.4% | – | |
| – | – | – | – | -331.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -30.1% | +1,813.1% | +120.8% | -59.1% | -93.5% | -14.0% | -18.3% | -22.4% | -27.3% | -14.6% | +139.0% | +2,340.8% | – | – | – | – | – | – | – | +56.8% | +1.4% | +0.8% | -3.7% | -4.4% | +7.6% | – | |
| – | – | – | – | -307.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -99.7% | +16,142.9% | -90.3% | -7.3% | -16.7% | -114.1% | – | – | – | – | +4.3% | -16.7% | +60.0% | -84.4% | +1,100.0% | +90.0% | +54.4% | -32.4% | -56.3% | +96.2% | -13.7% | -42.0% | +35.3% | – | |
| – | – | – | – | -307.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -337.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.